VR Logo

Collegium Pharmaceutical Inc. (COLL) download report


Healthcare | Drugs & Pharma

Collegium Pharmaceutical Inc. (COLL) Premium Coverage

52 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management.

IPO Date: 07-May-2015

Co-Founder & Chairman: Mr. Michael Thomas Heffernan B.S. Pharm, R.Ph.

Pres, CEO & Director: Mr. Joseph J. Ciaffoni

Listing: NASDAQ: COLL

Country: United States

Headquarters: Stoughton, MA

Website: https://www.collegiumpharma.com

Key Facts

Market cap: $574.15 Mln

Revenue (TTM): $272.90 Mln

Earnings (TTM): $42.79 Mln

Cash: $106.70 Mln

Total Debt: $777.67 Mln

Insider's Holding: 1.39%

Liquidity: Low

52 Week range: $14.04 - 25.66

Shares outstanding: 33,973,300

9 Years Aggregate:

  • CFO: $196.56 Mln
  • EBITDA: $62.95 Mln
  • Net Profit: $-193.99 Mln

Stock Performance

Time Period Collegium Pharmaceutical (COLL) S&P BSE Healthcare S&P Small-Cap 600
YTD-2.03-17.32-17.79
1 month16.93-4.56-2.72
3 months-4.19-10.61-12.17
1 Year-22.65-12.90-15.82
3 Years13.6719.537.14
5 Years7.349.106.20
10 Years--12.4410.33
As on 24-Jun-2022
Year Collegium Pharmaceutical (COLL) S&P Small-Cap 600 S&P BSE Healthcare
2021-6.7425.2720.87
2020-2.679.5761.45
201919.8620.86-3.55
2018-6.95-9.70-5.89
201718.5611.730.49
2016-43.3824.74-12.88